Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Perspective Therapeutics, Inc. Director's Dealing 2018

Nov 16, 2018

33510_dirs_2018-11-16_a0d17fc3-9577-49ce-babf-56af2d84f4e6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2018-11-16

Reporting Person: Cavanagh William (COO, CSO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-11-16 Common Stock P 10000 $0.40 Acquired 10000 Direct